1 Dagan R, KlugmanKP, Craug WA, et al.Evidence to support the rationale that bacterial eradication in respiratory tract infec-tion is an important aim of antimicrobial therapy[J]. J Antimi-crob Chemother, 2001;47:129-40
2 Jacobs MR, Weinberg W.Evidence-based guidelines for treat-ment of bacterial respiratory tract infections in the era of antibi-otic resistance[J]. Manag Care Interface, 2001;14:66-7
3 Burgess DS.Pharmacodynamic principles of antimicrobial thera-py in the prevention of resistance[J]. Chest, 1999;115(3s): 19s-23s
4 Gonzales R, Bartlett JG, Besser RE, et al.Principles of appro-priate antibiotic use for treatment of acute respiratory tract infec-tions in adults:background, specific aims, and methods[J]. Ann InternMed, 2001;134:479-86
5 Wise R, Honeybourne D.Pharmacokinetics and pharmacody-namics of fluoroquinolones in the respiratory tract[J]. Eur Respir J, 1999;14:221-9
6 Yates RR.New intervention strategiesfor reducing antibiotic re-sistance[J]. Chest, 1999;115(3s):24s-7s
7 Weber DJ, Raasch R, Rutala WA.Nosocomial infections in the ICU :the growing importance of antibiotic-resistant pathogens [J]. Chest, 1999;115(3s):34s-41s
8 Tessier PR, Nicolau DP, Onyeji CO, et al.Pharmacodynamics of intermittent -and continuous-infusion cefepime alone and in combination with once-daily tobramycin against Pseudomonas aeruginosa in an in vitro infection model[J]. Chemotherapy, 1999;45:284-95
9 Dulaney-Lopez AM, Rodriguez JC, Lopez-Samblas AM, et al. Limiting cefotaxime pediatric dosing to adult standards:a phar-macokinetic simulation study[J]. Int J Clin Pharmacol Ther, 1999;37:269-74
10 Morris RG, Sallustio BC, Vinks AA, et al.Some international approaches to aminoglycoside monitoring in the extended dosing interval era[J]. Ther Drug Monit, 1999;21:379-88
11 Kashuba AD, Nafziger AN, Drusano GL, et al.Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria[J]. Antimicrob Agents Chemother, 1999;43:623-9
12 Andes DR, Craig WA.Pharmacokinetics and pharmacodynam-ics of antibiotics in meningitis[J]. Infect Dis Clin North Am, 1999;13:595-618 |
